Herlev og Gentofte Hospital. ( Site 0401)

Herlev, Capital Region 2730

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Neoplasms, Urinary Bladder Neoplasms

Studies at this site

• Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002) — Running, not enrolling
• Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) — Running, not enrolling